Search





Search





Markets
/
Stocks
/
nasdaq-bdx
/

Becton Dickinson and Co

BDX

Add to Watchlist

149.430USD

-3.830-2.50%

Close 05/08, 16:00（ET）Quotes delayed by 15 min

42.65BMarket Cap

37.69P/E TTM



Becton Dickinson and Co

149.430

-3.830-2.50%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Becton Dickinson and Co

Currency: USD Updated: 2026-05-08

Key Insights

Becton Dickinson and Co's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 50 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 191.38.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Becton Dickinson and Co's Score

Industry at a Glance

Industry Ranking

50 / 206

Overall Ranking

136 / 4494

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Becton Dickinson and Co Highlights

StrengthsRisks

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 21.84B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 71.28%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 71.28%.

Fairly Valued

The company’s latest PE is 37.69, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 240.71M shares, decreasing 16.42% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 2.15K shares of this stock.

Analyst Rating

Based on 18 analysts

Buy

Current Rating

191.380

Target Price

+30.80%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-08

The current financial score of Becton Dickinson and Co is 7.55, ranking 65 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 4.71B, representing a year-over-year decrease of 10.58%, while its net profit experienced a year-over-year decrease of 200.97%.

Score

Industry at a Glance

Previous score

7.55

Change



Financials

5.76

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.41

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.66

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.82

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

8.11

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Becton Dickinson and Co's Company Valuation

Currency: USD Updated: 2026-05-08

The current valuation score of Becton Dickinson and Co is 7.31, ranking 95 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 37.69, which is 55.37% below the recent high of 58.55 and 37.54% above the recent low of 23.54.

Score

Industry at a Glance

Previous score

7.31

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 50/206

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-08

The current earnings forecast score of Becton Dickinson and Co is 7.25, ranking 146 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 201.92, with a high of 265.34 and a low of 183.00.

Score

Industry at a Glance

Previous score

7.25

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 18 analysts

Buy

Current Rating

191.380

Target Price

+30.80%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

116

Total

Median

Average

Company name

Ratings

Analysts

Becton Dickinson and Co

BDX

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-08

The current price momentum score of Becton Dickinson and Co is 7.01, ranking 96 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 158.59 and the support level at 141.64, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.71

Change

-1.7

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.225

Neutral

RSI(14)

44.860

Neutral

STOCH(KDJ)(9,3,3)

52.122

Buy

ATR(14)

4.403

High Vlolatility

CCI(14)

-0.841

Neutral

Williams %R

61.288

Sell

TRIX(12,20)

-0.283

Sell

StochRSI(14)

70.576

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

147.586

Buy

MA10

148.133

Buy

MA20

151.967

Sell

MA50

157.188

Sell

MA100

160.373

Sell

MA200

154.364

Sell

Institutional Confidence

Currency: USD Updated: 2026-05-08

The current institutional shareholding score of Becton Dickinson and Co is 7.00, ranking 76 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 87.47%, representing a quarter-over-quarter decrease of 10.90%. The largest institutional shareholder is First Eagle Investment, holding a total of 11.65M shares, representing 4.09% of shares outstanding, with 112.35% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

14.92M

+0.99%

T. Rowe Price Investment Management, Inc.

14.38M

-11.42%

State Street Investment Management (US)

13.99M

+0.84%

First Eagle Investment Management, L.L.C.

Star Investors

11.65M

+16.52%

MFS Investment Management

8.65M

+4.37%

Geode Capital Management, L.L.C.

6.89M

+0.79%

Wellington Management Company, LLP

5.30M

+1.28%

Putnam Investment Management, L.L.C.

5.18M

+2.35%

ClearBridge Investments, LLC

4.08M

-7.16%

BlackRock Financial Management, Inc.

3.95M

-7.61%

Risk Assessment

Currency: USD Updated: 2026-05-08

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Becton Dickinson and Co is 9.33, ranking 10 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.23. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Becton Dickinson and Co’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.